Kymera Therapeutics, Inc. Common Stock (KYMR) Stock Analysis
Price: $115.47 · -5.40%
Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
AnalystsStrong Buy30 analystsWhy is KYMR moving?
TechnicalKYMR fell 4.63% in an unusual technical pullback (Z-score -2.64) despite a positive price target raise from Stifel.
Price History
5-Year Weekly Candlestick Chart
Insider Transactions
Recent SEC Form 4 filings
- BuyGrant / award · filed 2026-07-27+76.0K sh2026-07-27
- BuyGrant / award · filed 2026-07-27+38.0K sh2026-07-27
- SellOption exercise · filed 2026-07-07-4441 sh2026-07-07
- SellOption exercise · filed 2026-07-07-45559 sh2026-07-07
- SellOpen market sale · filed 2026-07-07-50000 sh2026-07-07
+3 more recent filings
See how KYMR ranks on the Capex Tracker — top 50 capital spenders compared.
Recent Market Moves
See all KYMR moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Sep 23 | Regular | 115.56 | -5.33% | -3.07 |
| Sep 23 | After-hours | 115.47 | -5.40% | -3.11 |
| Sep 22 | After-hours | 122.06 | +3.73% | 2.06 |
Frequently Asked Questions about KYMR
What is the current Kymera Therapeutics, Inc. Common Stock (KYMR) stock price?
KYMR is trading at $115.47 in after-hours trading, down 5.40% on the session. PreMarketPrice tracks KYMR pre-market, intraday and after-hours prices.
When does Kymera Therapeutics, Inc. Common Stock report earnings?
No confirmed earnings date is currently scheduled for KYMR. The Earnings section lists recent reports and updates as dates are announced.
What sector does Kymera Therapeutics, Inc. Common Stock operate in?
Kymera Therapeutics, Inc. Common Stock operates in the Healthcare sector, within the Biological Products, (No Diagnostic Substances) industry. The Related Stocks section lists sector peers for comparison.
About Kymera Therapeutics, Inc. Common Stock (KYMR) Stock
Kymera Therapeutics, Inc. Common Stock (KYMR) is a US-listed stock operating in the Healthcare sector, specifically the Biological Products, (No Diagnostic Substances) industry. As of the latest update, Kymera Therapeutics, Inc. Common Stock is trading at $115.47, down 5.40% on the day with a market capitalization of $9.6 billion. The financial health score for KYMR has not yet been calculated — analysis data is being compiled. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for KYMR stock.
KYMR Stock Analysis & Key Metrics
On PreMarketPrice, you can track Kymera Therapeutics, Inc. Common Stock (KYMR) across multiple dimensions:
- Pre-market price & movement: Real-time KYMR stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Financial health score: A composite score based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for KYMR.
- Sector peers: Compare KYMR against 10 other healthcare stocks on key financial metrics.
Is KYMR a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate Kymera Therapeutics, Inc. Common Stock (KYMR) as an investment. The financial health score is being calculated.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Kymera Therapeutics, Inc. Common Stock (KYMR) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.